(FM) Oncología
Departamento académico
University of Antwerp
Amberes, BélgicaPublicaciones en colaboración con investigadores/as de University of Antwerp (13)
2024
-
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Annals of Oncology, Vol. 35, Núm. 11, pp. 981-992
-
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer–a plain language summary
Future Oncology, Vol. 20, Núm. 22, pp. 1531-1544
-
Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy
European Journal of Cancer, Vol. 208
2023
-
Progression-free survival and safety at 3.5 years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
European Journal of Cancer, Vol. 189
-
Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
Gynecologic Oncology, Vol. 170, pp. 300-308
2022
-
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study
Gynecologic Oncology, Vol. 166, Núm. 1, pp. 36-43
2021
-
In response to Haas RL et al.
Radiotherapy and Oncology
2020
-
ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer
Radiotherapy and Oncology, Vol. 149, pp. 150-157
-
ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in primary locally advanced rectal cancer
Clinical and Translational Radiation Oncology, Vol. 25, pp. 29-36
-
Niraparib in Patients With Newly Diagnosed Advanced Ovarian Cancer
Obstetrical and Gynecological Survey
2019
-
Niraparib in patients with newly diagnosed advanced ovarian cancer
New England Journal of Medicine, Vol. 381, Núm. 25, pp. 2391-2402
2015
-
Looking into the "Garden of the Hesperides": New drugs for hepatocellular carcinoma
Minerva Chirurgica, Vol. 70, Núm. 2, pp. 119-129
-
cMET in NSCLC: Can we cut off the head of the Hydra? From the pathway to the resistance
Cancers, Vol. 7, Núm. 2, pp. 556-573